Companies that stay ahead of the curve and adapt their strategies now will be ready to lead the next wave of innovation in obesity care
Vendors who promise "100% pure pharmaceutical-grade retatrutide" at research chemical prices are either lying about the grade or lying about the purity
Liraglutide shows dose-dependent nausea ratesVictoza (for diabetes) has rates around 10-17% depending on dose, while Saxenda (3.0 mg for weight management) has significantly higher nausea rates of approximately 39% according to its SmPC
Although physical therapy and drug management still dominate OA treatment, the establishment of a stepwise nutritional intervention plan is believed to assist in delaying OA progression, reducing drug use, and avoiding surgical risks
In-Shape Teams With Korb Health To Offer GLP-1s & Health Services In-Shape partners with Korb Health to offer GLP-1s, hormone therapy and more, merging fitness with clinical care
These options are effective, less invasive, and convenient for many patients